Tian Zhang, MD, MHS
Dr. Zhang received her MD from the Harvard-MIT Health Sciences and Technology (HST) program and completed post-graduate training at Duke University, where she remained on faculty until 2021. She is currently Associate Professor and Director of Clinical Research within the Division of Hematology and Oncology and Department of Internal Medicine at University of Texas Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center. She leads the multi-disease and precision oncology portfolio of trials within the cancer center. Clinically she specializes in genitourinary malignancies and is a clinical researcher focused on improving novel therapies and biomarkers for patients with renal, prostate, and urothelial cancers. She serves as co-chair of the NCI GU Steering Committee Renal Task Force.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Pfizer, Eli Lilly, Tempus, ALX Oncology, Exelixis, Merck, OncoC4Topic:PI (research funding)Date added:03/22/2022Date updated:04/11/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Pfizer, MJH Associates, Vaniam, Aptitude Health, PeerView, Clinical Care Options, Mashup MediaTopic:ConsultantDate added:03/22/2022Date updated:04/11/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Merck, Exelixis, Sanofi-Aventis, Janssen, AstraZeneca, Pfizer, BMS, SeaGen, Eisai, Aveo Pharmaceuticals, Bayer, Eli Lilly, Novartis, Gilead, EMD SeronoTopic:Advisory BoardDate added:03/22/2022Date updated:04/11/2024